Alpha 2.0
Login Register
» Articles » PMID: 40001254

Risk Factors for Detection of Pseudomonas Aeruginosa in Clinical Samples Upon Hospital Admission

Overview
Journal Antimicrob Resist Infect Control
Publisher Biomed Central
Specialty Infectious Diseases
Date 2025 Feb 26
PMID 40001254
Authors
Romeo Reyle
Frank Schwab
Selin Saydan
Michael Behnke
Rasmus Leistner
Petra Gastmeier
Christine Geffers
Tobias Siegfried Kramer
Affiliations
Soon will be listed here.
Abstract

Background/introduction: Antipseudomonal antibiotics are frequently used in patients admitted to hospitals. Many of these substances are classified as a reserve or watch status by the WHO. Inappropriate risk assessment of invasive detection of P. aeruginosa (PAE) can be a reason for overuse of antipseudomonal antibiotics. Therefore it is important to define relevant and specific risk factors for invasive PAE detection.

Objective: The objective of this study was to identify risk factors for invasive detection of PAE in patients upon hospital admission.

Methods: All patients 18 years of age and older with a detection of PAE and/or Enterobacterales in clinical samples taken within 48 h of admission to one of the hospitals of Charité Universitätsmedizin Berlin between 2015 and 2020 were included into this retrospective cohort study.

Results: Overall, we included a total of 27,710 patients. In 3,764 (13.6%) patients PAE was detected in clinical samples taken within 48 h after admission. The most frequently detected Enterobacterales was E. coli in 14.142 (51%) patients followed by Klebsiella spp. in 4.432 (16%) patients. Multivariable regression analysis identified that prior colonisation with a multi drug resistant PAE or detection of a PAE in clinical samples during a previous hospitalisation increased the risk for invasive detection of PAE (OR 39.41; 95% CI 28.54-54.39) and OR 7.87 (95% CI 6.60-9.38) respectively. Admission to a specialised ward for patients with cystic fibrosis was associated with an increased risk (OR 26.99; 95% CI 20.48-35.54). Presence of chronic pulmonary disease (OR 2.05; 95% CI 1.85-2.26), hemiplegia (OR 2.16; 95% CI 1.90-2.45) and male gender (OR 1.60; 95% CI 1.46-1.75) were associated with a modest increase in risk for presence of PAE.

Conclusion: Patients with a prior detection of P. aeruginosa or admission to a cystic fibrosis ward had the highest risk for invasive detection of P. aeruginosa. Adherence to specific risk scores based on local risk factors could help to optimize prescription of anti-pseudomonal antibiotics that categorized as reserve and watch.

References
1.
Fujitani S, Sun H, Yu V, Weingarten J . Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest. 2011; 139(4):909-919. DOI: 10.1378/chest.10-0166. View
2.
Munting A, Regina J, Damas J, Lhopitallier L, Kritikos A, Guery B . Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital. Clin Microbiol Infect. 2021; 28(4):558-563. DOI: 10.1016/j.cmi.2021.03.034. View
3.
Hyun H, Song J, Yoon J, Seong H, Noh J, Cheong H . Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes. PLoS One. 2022; 17(6):e0270261. PMC: 9242491. DOI: 10.1371/journal.pone.0270261. View
4.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View
5.
Waagsbo B, Tranung M, Damas J, Heggelund L . Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study. BMC Pulm Med. 2022; 22(1):379. PMC: 9569007. DOI: 10.1186/s12890-022-02178-6. View